IFP Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.4M | Buy |
39,148
+38,977
| +22,794% | +$6.81M | 0.15% | 146 |
|
|
2025
Q4 | $29.1K | Sell |
171
-26
| -13% | -$3.99K | ﹤0.01% | 2512 |
|
|
2025
Q3 | $26K | Buy |
197
+44
| +29% | +$5.28K | ﹤0.01% | 2442 |
|
|
2025
Q2 | $26.8K | Sell |
153
-39
| -20% | -$4.24K | ﹤0.01% | 2384 |
|
|
2025
Q1 | $25.3K | Buy |
192
+5
| +3% | +$652 | ﹤0.01% | 2203 |
|
|
2024
Q4 | $24.5K | Buy |
+187
| New | +$22K | ﹤0.01% | 2155 |
|
|
2024
Q3 | – | Sell |
-177
| Closed | -$19.4K | – | 472 |
|
|
2024
Q2 | $18.9K | Buy |
177
+10
| +6% | +$1.1K | ﹤0.01% | 2112 |
|
|
2024
Q1 | $20.1K | Sell |
167
-1,463
| -90% | -$179K | ﹤0.01% | 1970 |
|
|
2023
Q4 | $200K | Buy |
1,630
+1,609
| +7,662% | +$201K | 0.01% | 943 |
|
|
2023
Q3 | $2.72K | Sell |
21
-7,603
| -100% | -$1.01M | ﹤0.01% | 2739 |
|
|
2023
Q2 | $945K | Buy |
7,624
+7,543
| +9,312% | +$1.01M | 0.04% | 446 |
|
|
2023
Q1 | $13.8K | Sell |
81
-277
| -77% | -$41K | ﹤0.01% | 2166 |
|
|
2022
Q4 | $64K | Buy |
358
+75
| +27% | +$11K | ﹤0.01% | 2068 |
|
|
2022
Q3 | $52K | Buy |
283
+67
| +31% | +$10.2K | ﹤0.01% | 2336 |
|
|
2022
Q2 | $38K | Hold |
216
| – | – | ﹤0.01% | 2350 |
|
|
2022
Q1 | $38K | Buy |
216
+190
| +731% | +$27.6K | ﹤0.01% | 2350 |
|
|
2021
Q4 | $4K | Sell |
26
-9
| -26% | -$1.18K | ﹤0.01% | 2572 |
|
|
2021
Q3 | $5K | Buy |
35
+2
| +6% | +$302 | ﹤0.01% | 2556 |
|
|
2021
Q2 | $6K | Buy |
+33
| New | +$5.72K | ﹤0.01% | 2405 |
|
|
2020
Q2 | – | Sell |
-214
| Closed | -$23.7K | – | 2837 |
|
|
2020
Q1 | $22K | Buy |
214
+205
| +2,278% | +$26.5K | ﹤0.01% | 1441 |
|
|
2019
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 2677 |
|
|
2019
Q3 | $1K | Buy |
+9
| New | +$1.21K | ﹤0.01% | 2875 |
|
|
2019
Q1 | $146K | Buy |
1,017
+238
| +31% | +$31K | 0.02% | 560 |
|
|
2018
Q4 | $95K | Sell |
779
-245
| -24% | -$36.3K | 0.01% | 1224 |
|
|
2018
Q3 | $172K | Sell |
1,024
-62
| -6% | -$10.7K | 0.01% | 1160 |
|
|
2018
Q2 | $187K | Buy |
1,086
+925
| +575% | +$151K | 0.01% | 1094 |
|
|
2018
Q1 | $22K | Hold |
161
| – | – | ﹤0.01% | 2324 |
|
|
2017
Q4 | $22K | Sell |
161
-14
| -8% | -$1.94K | ﹤0.01% | 2357 |
|
|
2017
Q3 | $26K | Sell |
175
-124
| -41% | -$18.8K | ﹤0.01% | 2431 |
|
|
2017
Q2 | $46K | Buy |
299
+140
| +88% | +$21.4K | ﹤0.01% | 2016 |
|
|
2017
Q1 | $23K | Buy |
159
+81
| +104% | +$10.6K | ﹤0.01% | 2402 |
|
|
2016
Q4 | $9K | Sell |
78
-515
| -87% | -$57.4K | ﹤0.01% | 2969 |
|
|
2016
Q3 | $72K | Buy |
593
+19
| +3% | +$2.56K | ﹤0.01% | 1582 |
|
|
2016
Q2 | $81K | Sell |
574
-443
| -44% | -$65.3K | ﹤0.01% | 1464 |
|
|
2016
Q1 | $146K | Buy |
1,017
+289
| +40% | +$36K | 0.02% | 560 |
|
|
2015
Q4 | $102K | Buy |
+728
| New | +$101K | 0.01% | 1171 |
|
Other funds holding JAZZ
VPM
VCM
EC
IFP Advisors's JAZZ Position: Q1 2026 in Review
IFP Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 22,794% in Q1 2026, buying an estimated $6.81M and bringing the position to 39,148 shares worth $7.4M. The position accounts for 0.15% of the portfolio, ranked #146.
IFP Advisors first reported a position in JAZZ in Q4 2015 and has held it in 36 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- IFP Advisors held 39,148 shares of Jazz Pharmaceuticals worth $7.4M as of Q1 2026.
- IFP Advisors bought 38,977 Jazz Pharmaceuticals shares in Q1 2026, an estimated $6.81M.
- Jazz Pharmaceuticals made up 0.15% of IFP Advisors's portfolio in Q1 2026, its #146 holding.
- IFP Advisors first reported a position in Jazz Pharmaceuticals in Q4 2015 and has held it in 36 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.